Search

Your search keyword '"Immunological Biomarkers"' showing total 202 results

Search Constraints

Start Over You searched for: Descriptor "Immunological Biomarkers" Remove constraint Descriptor: "Immunological Biomarkers"
202 results on '"Immunological Biomarkers"'

Search Results

1. Immunological Biomarkers in Autism Spectrum Disorder: The Role of TNF-Alpha and Dependent Trends in Serum IL-6 and CXCL8.

2. Neutrophil-to-Lymphocyte Ratio and Cytokine Profiling as Predictors of Disease Severity and Survival in Unvaccinated COVID-19 Patients.

3. Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells.

4. Immunological Biomarkers in Autism Spectrum Disorder: The Role of TNF-Alpha and Dependent Trends in Serum IL-6 and CXCL8

5. Neutrophil-to-Lymphocyte Ratio and Cytokine Profiling as Predictors of Disease Severity and Survival in Unvaccinated COVID-19 Patients

7. Diagnostic Value of Immunological Biomarkers in Children with Asthmatic Bronchitis and Asthma.

8. Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells

9. Specific Clinical and Immunological Changes Following Mesenchymal Stem Cell Transplantation in COVID-19-induced Acute Respiratory Distress Syndrome Patients: A Phase-I Clinical Trial.

10. Diagnostic Value of Immunological Biomarkers in Children with Asthmatic Bronchitis and Asthma

12. Autism spectrum disorder diagnosis using a new panel of immune- and inflammatory-related serum biomarkers: A case-control multicenter study

13. Specific Clinical and Immunological Changes Following Mesenchymal Stem Cell Transplantation in COVID-19–induced Acute Respiratory Distress Syndrome Patients: A Phase-I Clinical Trial

14. Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.

15. A glance at the emerging diagnostic biomarkers in the most prevalent genitourinary cancers.

16. Clinical Characteristics and Patterns of Immune Responses in COVID-19 Patients From a Rural Community Hospital.

18. Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy

19. Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection

20. Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection.

21. Cell-Mediated Immunological Biomarkers and Their Diagnostic Application in Livestock and Wildlife Infected With Mycobacterium bovis

23. Cell-Mediated Immunological Biomarkers and Their Diagnostic Application in Livestock and Wildlife Infected With Mycobacterium bovis.

24. Biomarkers associated with COVID-19 disease progression.

25. Organ involvement in immunoglobulin a vasculitis (Henoch-Shönlein purpura) children: Relation to immune profile.

26. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study.

27. Prospection of immunological biomarkers for characterization and monitoring of asymptomatic Leishmania (Leishmania) infantum infection.

28. Estimation of serum levels of some immunological and Heamatological changes in patient infected with Salmonella bacteria in Sammara city, Iraq.

29. Community-Acquired Pneumonia in Adults: What's New Focusing on Epidemiology, Microorganisms and Diagnosis?

30. Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome.

31. B cell, CD8+ T cell and gamma delta T cell infiltration alters alveolar immune cell homeostasis in HIV-infected Malawian adults [version 3; referees: 2 approved, 1 approved with reservations]

32. Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease

33. Characterisation of innate lymphoid cell populations at different sites in mice with defective T cell immunity [version 3; referees: 2 approved]

34. B cell, CD8 + T cell and gamma delta T cell infiltration alters alveolar immune cell homeostasis in HIV-infected Malawian adults [version 2; referees: 1 approved, 2 approved with reservations]

35. New frontiers in metabolomics: from measurement to insight [version 1; referees: 3 approved]

36. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma [version 3; referees: 2 approved]

37. Mean Platelet Volume (MPV) as an indicator of disease activity and severity in lupus [version 3; referees: 2 approved]

38. Mean Platelet Volume (MPV) as an indicator of disease activity and severity in lupus [version 2; referees: 1 approved, 1 approved with reservations]

39. Challenges in microbiological diagnosis of invasive Aspergillus infections [version 1; referees: 2 approved]

40. Monitoring disease activity and severity in lupus [version 1; referees: 2 approved with reservations]

41. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma [version 2; referees: 2 approved]

42. Nephrotoxicities [version 1; referees: 2 approved]

43. Recent advances in understanding antiphospholipid syndrome [version 1; referees: 2 approved]

44. Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial [version 1; referees: 3 approved]

45. Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial [version 3; referees: 2 approved]

46. Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children [version 2; referees: 2 approved]

47. Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial [version 2; referees: 2 approved]

48. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma [version 3; referees: 2 approved]

49. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma [version 2; referees: 2 approved]

50. Registered human trials addressing environmental and occupational toxicant exposures: Scoping review of immunological markers and protective strategies

Catalog

Books, media, physical & digital resources